Biological E’s recombinant protein Covid-19 vaccine, Corbevax, could well emerge as the most affordable of vaccines in the Indian market once it gets emergency use approval (EUA). Corbevax is slated to be rolled out at a sub-Rs 500 pricing, not for one dose but both the doses, and may even be priced below Rs 400 for two doses.Biological E’s recombinant protein Covid-19 vaccine, Corbevax, could well emerge as the most affordable of vaccines in the Indian market once it gets emergency use approval (EUA). Corbevax is slated to be rolled out at a sub-Rs 500 pricing, not for one dose but both the doses, and may even be priced below Rs 400 for two doses.